Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720949 · ClinicalTrials.gov registry record · Phase 4
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
A Phase 4 study of Anterior Cruciate Ligament Injuries and ACL, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 192
- Enrollment target
- 1
- Study location
NCT05720949 is a Phase 4 study of Anterior Cruciate Ligament Injuries and ACL that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 192 participants, below the 315-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05720949, a Phase 4 study of Anterior Cruciate Ligament Injuries and ACL, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial is to assess a new analgesia regimen that includes the addition of genicular never blocks to our current standard regimen of peripheral nerve blocks, which includes an adductor canal block (ACB) and interspace between the popliteal artery and capsule of the posterior knee block (IPACK). The main questions it aims to answer are: 1. Does addition of genicular nerve blocks to standard peripheral block regimen significantly reduce the mean opioid consumption by 33% in the first 24 hours? 2. Does genicular nerve blocks reduce NRS pain scores? 3. Does genicular nerve blocks facilitate earlier discharge? 4. Does genicular nerve blocks last longer than 24 hours? 5. Does genicular nerve blocks improve pain management? Eligible patients are those undergoing an anterior cruciate ligament repair at the Hospital for Special Surgery and participants will be randomized to receive the intervention (genicular nerve block) or the standard of care.
Conditions Studied
Interventions
- DRUG Genicular Nerve Block with bupivacaine and preservative free dexamethasone
Study Locations (1)
New York
- HSS Sports Medicine Institute West Side - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2023-01-12 |
| Est. Completion | 2024-12-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05720949
The ClinicalTrials.gov registry entry for NCT05720949 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 315-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (39% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 1 intervention - of which Genicular Nerve Block with bupivacaine and preservative free dexamethasone is the first listed.
NCT05720949 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05720949 about?
NCT05720949 is a clinical study titled "Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery". The purpose of this randomized controlled trial is to assess a new analgesia regimen that includes the addition of genicular never blocks to our current standard regimen of peripheral nerve blocks, which includes an adductor canal block (ACB) and interspace between the popliteal artery and capsule o...
What is the current status of trial NCT05720949?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 192 participants. The study started on 2023-01-12. Estimated completion is 2024-12-02.
What conditions does trial NCT05720949 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, ACL.
What interventions are being tested in trial NCT05720949?
The interventions under investigation include: Genicular Nerve Block with bupivacaine and preservative free dexamethasone (DRUG).
Who is sponsoring clinical trial NCT05720949?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720949 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
RECRUITING · Phase 4
-
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
RECRUITING · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.